COMPANIES COVERED
SanofiDownload FREE Report Sample
Download Free sampleAmiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.
Amiodarone Market contains market size and forecasts of Amiodarone in global, including the following market information:
Global Amiodarone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Amiodarone Market Sales, 2017-2022, 2023-2028, (M Doses)
Global top five Amiodarone companies in 2021 (%)
The global Amiodarone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Amiodarone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amiodarone include Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals(Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals and North China Pharmaceutical Company and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amiodarone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amiodarone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Amiodarone Market Segment Percentages, by Type, 2021 (%)
Tablet Amiodarone
Capsule Amiodarone
Injection Amiodarone
Global Amiodarone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Amiodarone Market Segment Percentages, by Application, 2021 (%)
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Global Amiodarone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)
Global Amiodarone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amiodarone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Amiodarone revenues share in global market, 2021 (%)
Key companies Amiodarone sales in global market, 2017-2022 (Estimated), (M Doses)
Key companies Amiodarone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals(Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy